Author

A. Albillos

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Randomised, double-blind, placebo-controlled trial of faecal microbiota transplantation in patients with decompensated cirrhosis: the Livergut protocol

Abstract Introduction Cirrhosis represents the final stage of most chronic liver diseases and remains a major global cause of morbidity and mortality. Alterations in the gut microbiome correlate with disease severity and complications such as hepatic encephalopathy (HE) and acute-on-chronic liver failure (ACLF). Prelim...

A. Juanola, M. Moreta, C. Solé et al. · BMJ Open · 0 citations

Review Open access Oct 2026

Anticoagulation in cirrhosis: Indications, drug selection, and disease-modifying potential.

Anticoagulation in cirrhosis has evolved from a perceived contraindication to an integral component of modern liver disease management. Recognition of the fragile rebalanced hemostatic state has challenged the traditional concept of cirrhosis as an exclusively hemorrhagic disorder and provided the biological rationale...

Luis Téllez, Antonio Guerrero, J. Donate et al. · Annals of Hepatology · 0 citations

Review Open access Oct 2026

Portopulmonary hypertension: an integrated approach to diagnosis, risk stratification, and management.

Portopulmonary hypertension (PoPH) is a complex and underrecognized form of pulmonary arterial hypertension arising in the setting of portal hypertension, in which outcomes are driven by the interplay between pulmonary vascular disease and liver dysfunction. Despite advances in hemodynamic definitions and targeted ther...

J. Donate, S. del Prado, Andrés Tenes et al. · Annals of Hepatology · 0 citations